Early diastolic mitral annular velocity
e′ (E′) · Pulsed tissue Doppler, apical 4-chamber, sample volume on the septal and lateral mitral annulus; average the two
Normal range & thresholds
Age-stratified abnormal thresholds (2025 ASE, step 1 of the algorithm):
Age-independent cut-points used within the LAP algorithm: septal e′ ≤6 cm/s, lateral e′ ≤7 cm/s, average e′ ≤6.5 cm/s.[2]
| Age (y) | Septal e′ | Lateral e′ | Average e′ |
|---|---|---|---|
| 20–39 | <7 cm/s | <10 cm/s | <9 cm/s |
| 40–65 | <6 cm/s | <8 cm/s | <7 cm/s |
| >65 | <6 cm/s | <7 cm/s | <6.5 cm/s |
Pathophysiology
e′ is the velocity at which the mitral annulus recoils toward the atrium in early diastole, and it is a direct mechanical readout of active relaxation: SERCA2a-mediated calcium re-uptake, cross-bridge detachment, and the release of restoring forces stored during systolic twist. Because relaxation is an ATP-consuming, energy-dependent process, e′ falls early in ischaemia, hypertrophy, fibrosis, infiltration and ageing — usually before any of the pressure-based indices move. Critically, e′ is relatively preload-independent once relaxation is impaired, which is exactly what makes it a valid denominator for E in the E/e′ ratio.[2]
Raised by
- Youth and athletic conditioning (e′ >15 cm/s lateral is normal in the young)
- Constrictive pericarditis — annulus paradoxus: medial e′ is preserved or high (>7–8 cm/s) despite severe heart failure, because longitudinal motion is spared while the rigid pericardium restricts lateral expansion; and annulus reversus, septal e′ exceeding lateral e′ — both are among the most specific signs in echocardiography[57]
- After successful decongestion and after relief of ischaemia (modest true improvement)
- Significant mitral regurgitation with a normal ventricle (falsely reassuring)
Lowered by
- Ageing — the dominant physiological determinant; interpret only against an age-matched threshold
- Left ventricular hypertrophy of any cause; hypertension
- Ischaemia and prior infarction (regional if the sampled wall is involved)
- Infiltrative and storage disease — amyloid (with s′ and a′ also <5 cm/s: the ‘5-5-5 sign’), Fabry, sarcoid, haemochromatosis[2,30]
- HCM, restrictive cardiomyopathy, diabetes, chronic kidney disease, obesity
- Any cause of reduced systolic function (systolic and diastolic dysfunction travel together)
- Mechanical constraint: mitral annular calcification, annuloplasty ring, mitral prosthesis, prior mitral surgery — the annulus cannot move, whatever the myocardium is doing
Technique & pitfalls
- Angle of insonation <20° to longitudinal annular motion — this is a velocity, and cosine error is unforgiving.
- Sample volume 5–10 mm placed on the annulus, kept within its excursion throughout the cycle.
- Sweep speed 50–100 mm/s; low wall filter; gain low enough to see a clean spectral edge without spectral broadening.
- Measure and report both septal and lateral and their average. Where they diverge (regional infarct, LBBB, pacing, constriction) the divergence is itself diagnostic information.[2,57]
- In left bundle branch block, RV pacing or after cardiac surgery, the septal value is unreliable — the 2025 guideline directs you to the lateral annulus.[2]
- In pulmonary hypertension, use the lateral annulus, because septal flattening from RV pressure corrupts the septal signal.[2]
Pseudo-change & artefact
- Mitral annular calcification and mitral prostheses tether the annulus and lower e′ without any relaxation abnormality — the largest single source of false diastolic dysfunction.
- Angle error and sample-volume drift into the cavity.
- Regional wall motion abnormality in the sampled segment makes a single-site value non-representative.
- Cardiac translation and respiratory motion.
- High wall filter truncating the low-velocity signal.
- Load: e′ is relatively but not completely preload-independent — in a normal ventricle (and only there) it does rise with preload.
Treatment thresholds
- e′ is the entry point of the 2025 ASE algorithm, not a treatment target. Its formal role: if e′ is reduced, one additional abnormal criterion establishes diastolic dysfunction; if e′ is preserved, two are required.[2]
- Constrictive pericarditis: medial e′ >7–8 cm/s (annulus paradoxus) and septal > lateral (annulus reversus) support constriction over restriction, and that distinction is the decision to operate — pericardiectomy versus medical management of an infiltrative cardiomyopathy.[31,57]
- Amyloidosis: the 5-5-5 pattern (s′, e′, a′ all <5 cm/s) is a red flag that triggers free light chains and bone scintigraphy — which lead to disease-modifying therapy.[30]
- Heart transplant follow-up: a fall in e′ with a rising E/e′ supports the assessment for rejection or restrictive physiology, using the guideline’s transplant-specific algorithm.[2]
Next step
- Next: compute E/e′ and measure peak TR velocity — the three primary variables must be assessed together (card 19).
- Then: if these are discordant or incomplete, add LA reservoir strain (≤18% abnormal), pulmonary vein S/D (≤0.67 abnormal), LAVI (>34 mL/m²) and IVRT.[2]
- Then: when e′ is low with thick walls, take the infiltrative pathway — strain bull’s-eye, ECG voltage, CMR mapping, light chains, bone scintigraphy.[30]
- Then: when e′ is low with a normal-looking heart and exertional dyspnoea, proceed to diastolic stress echocardiography.[105,106]
Drugs
- No drug reliably and substantially raises e′. This is the honest answer, and it is worth saying in the report: relaxation abnormalities are structural.
- Small improvements follow LVH regression with RAAS blockade, relief of ischaemia by revascularisation, rate control that lengthens diastole, and effective long-term decongestion.[66,67]
- SGLT2 inhibitors and ARNI improve E/e′ mostly by lowering E (filling pressure), with only marginal change in e′.[68,69,82]
- Mavacamten improves e′ and E/e′ in obstructive HCM.[72]
- Enzyme replacement in early Fabry improves e′; tafamidis slows deterioration in ATTR.[75]
Reversibility
The least reversible of the diastolic parameters. e′ reflects fibrosis, hypertrophy and infiltration — structural properties that change over months to years, if at all. Expect improvement of roughly 1–2 cm/s at best after LVH regression or revascularisation, over 6–12 months. This inertia is a strength, not a weakness: it is precisely why e′ is trustworthy when a diuretic has cosmetically normalised everything else.[2]